In 2013, ILSI Europe reviewed the health benefits of vitamin K2 (Beulens et al., 2013, British Journal of Nutrition). Since that time, lots of new science has emerged: new health benefits studied extend beyond bone health to cardiovascular, immune, or nerve health, to name a few.
This new activity will be conducted by an ILSI Europe expert group comprising at least 50% scientists from academia and the public sector, and up to 50% industry scientists. Scientists will critically review the substantiation of the different health benefits of vitamin K2. They will also discuss the optimal markers to be used to monitor vitamin K2 status. Finally, they will perform a nutrition economic study. The expert group will participate in meetings in Brussels, monthly conference calls, and write a scientific paper, to be published in a peer-reviewed journal.
Expert group members
- Delphine Saulnier, Novozymes, OneHealth
- Amélie Decherf, Gnosis by Lesaffre
- Katarzyna Maresz, Independent Researcher, Krakow, Poland
- Szabolcs Péter, DSM-Firmenich
- Naomi Venlet, ILSI Europe
- Isabelle Guelinckx, ILSI Europe
Download the activity poster
This activity should result in 1/ an updated critical review paper of the health benefits associated with vitamin K2, 2/ a consensus on the vitamin K2 status markers to be used, 3/a determination of healthcare cost savings in Europe due to vitamin K2 supplementation.
The expected outcome of this activity is an updated assessment of the health benefits of different forms of vitamin K2 to the scientific and industrial community, and public at large. The estimation of healthcare cost savings with adequate intake of the different forms of vitamin K2 will be helpful to guide clinicians and public health organizations.